Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2002;99:389-394
© 2002 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, K. K.
Right arrow Articles by Baracat, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, K. K.
Right arrow Articles by Baracat, E. C.

ORIGINAL RESEARCH

Benefits of Soy Isoflavone Therapeutic Regimen on Menopausal Symptoms

Kyung K. Han, MD, Jose M. Soares, Jr, MD, Mauro A. Haidar, MD, PhD, Geraldo Rodrigues de Lima, MD, PhD and Edmund C. Baracat, MD, PhD

From the Department of Gynecology, Escola Paulista de Medicina/Federal University of Sao Paulo, Sao Paulo, Brazil.

Address reprint requests to: Edmund C. Baracat, MD, PhD, Federal University of Sao Paulo, Department of Gynecology, Rua Dr. Diogo de Faria, 1087 cj. 610 v. Clementino, Sao Paulo SP 04037-003, Brazil; E-mail: baracat.toco{at}epm.br

OBJECTIVE: To examine the change in menopausal symptoms and cardiovascular risk factors in response to 4 months of daily 100-mg soy isoflavone in postmenopausal women.

METHODS: In this double-blind, placebo-controlled study, 80 women were randomly assigned to isoflavone (n = 40) and placebo (n = 40) treatment. The menopausal Kupperman index was used to assess change in menopausal symptoms at baseline and after 4 months of treatment. Cardiovascular risk factors were assessed by evaluating plasma lipid levels, body mass index, blood pressure, and glucose levels in the participants. To examine the effects of this regime on endogenous hormone levels, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and 17ß-estradiol were measured. Transvaginal sonography was performed to quantify endometrial thickness.

RESULTS: The data showed a decrease in menopausal symptoms (P < .01, paired t test, two-tailed, between baseline and isoflavone groups, and P < .01, unpaired t test, between placebo and isoflavone groups). Total cholesterol and low-density lipoprotein decreased significantly in the isoflavone group compared with the baseline or placebo group (P < .001, paired t test, two-tailed, between baseline and isoflavone groups, and P < .01, unpaired t test, between placebo and isoflavone groups). The isoflavone treatment appeared to have no effect on blood pressure, plasma glucose, and high-density lipoprotein and triglyceride levels.

CONCLUSION: This study suggests that isoflavone 100-mg regime treatment may be a safe and effective alternative therapy for menopausal symptoms and may offer a benefit to the cardiovascular system.




This article has been cited by other articles:


Home page
Arch Intern MedHome page
F. K. Welty, K. S. Lee, N. S. Lew, and J.-R. Zhou
Effect of Soy Nuts on Blood Pressure and Lipid Levels in Hypertensive, Prehypertensive, and Normotensive Postmenopausal Women
Arch Intern Med, May 28, 2007; 167(10): 1060 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
L. B. Michaud, J. P. Karpinski, K. L. Jones, and J. Espirito
Dietary supplements in patients with cancer: Risks and key concepts, part 2
Am. J. Health Syst. Pharm., March 1, 2007; 64(5): 467 - 480.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. M. Newton, S. D. Reed, A. Z. LaCroix, L. C. Grothaus, K. Ehrlich, and J. Guiltinan
Treatment of Vasomotor Symptoms of Menopause with Black Cohosh, Multibotanicals, Soy, Hormone Therapy, or Placebo: A Randomized Trial
Ann Intern Med, December 19, 2006; 145(12): 869 - 879.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Nedrow, J. Miller, M. Walker, P. Nygren, L. H. Huffman, and H. D. Nelson
Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review.
Arch Intern Med, July 24, 2006; 166(14): 1453 - 1465.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. D. Nelson, K. K. Vesco, E. Haney, R. Fu, A. Nedrow, J. Miller, C. Nicolaidis, M. Walker, and L. Humphrey
Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
JAMA, May 3, 2006; 295(17): 2057 - 2071.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. T. van der Schouw, L. Sampson, W. C. Willett, and E. B. Rimm
The Usual Intake of Lignans but Not That of Isoflavones May Be Related to Cardiovascular Risk Factors in U.S. Men
J. Nutr., February 1, 2005; 135(2): 260 - 266.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. Williamson and C. Manach
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies
Am. J. Clinical Nutrition, January 1, 2005; 81(1): 243S - 255S.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
E. E. Krebs, K. E. Ensrud, R. MacDonald, and T. J. Wilt
Phytoestrogens for Treatment of Menopausal Symptoms: A Systematic Review
Obstet. Gynecol., October 1, 2004; 104(4): 824 - 836.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. A. Tice, B. Ettinger, K. Ensrud, R. Wallace, T. Blackwell, and S. R. Cummings
Phytoestrogen Supplements for the Treatment of Hot Flashes: The Isoflavone Clover Extract (ICE) Study: A Randomized Controlled Trial
JAMA, July 9, 2003; 290(2): 207 - 214.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
C. E. Piersen
Phytoestrogens in Botanical Dietary Supplements: Implications for Cancer
Integr Cancer Ther, June 1, 2003; 2(2): 120 - 138.
[Abstract] [PDF]


Home page
Obstet GynecolHome page
E. Nikander, A. Kilkkinen, M. Metsa-Heikkila, H. Adlercreutz, P. Pietinen, A. Tiitinen, and O. Ylikorkala
A Randomized Placebo-Controlled Crossover Trial With Phytoestrogens in Treatment of Menopause in Breast Cancer Patients
Obstet. Gynecol., June 1, 2003; 101(6): 1213 - 1220.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. S. Kurzer
Phytoestrogen Supplement Use by Women
J. Nutr., June 1, 2003; 133(6): 1983S - 1986.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02)
Evid. Based Nurs., January 1, 2003; 6(1): e1 - 1.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
F. Kronenberg and A. Fugh-Berman
Complementary and Alternative Medicine for Menopausal Symptoms: A Review of Randomized, Controlled Trials
Ann Intern Med, November 19, 2002; 137(10): 805 - 813.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
M. P. Warren
The Effects of Phytoestrogen Supplementation in Postmenopausal Women
Reproductive Sciences, July 1, 2002; 9(4): 184 - 185.
[PDF]


Home page
JWatch Women's HealthHome page
Another Look at Isoflavones for Menopausal Symptoms
Journal Watch Women's Health, June 18, 2002; 2002(618): 4 - 4.
[Full Text]


Home page
JWatch PsychiatryHome page
Soy Isoflavones Reduce Menopausal Symptoms
Journal Watch Psychiatry, May 23, 2002; 2002(523): 10 - 10.
[Full Text]


Home page
JWatch GeneralHome page
Soy Isoflavones Reduce Menopausal Symptoms
Journal Watch (General), April 9, 2002; 2002(409): 4 - 4.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Obstetricians and Gynecologists.